News Chart Incannex Healthcare Inc.

Equities

IXHL

US45333F1093

Market Closed - Nasdaq Other stock markets 21:30:01 14/06/2024 BST			5-day change	1st Jan Change
3.32 ^USD	+5.40%		+2.15%	-28.45%

05-30	Incannex Healthcare Inc. Announces Patient Dosing Commencement in RePOSA Phase 2/3 Clinical Trial Protocol to Assess IHL-42X Drug in Patients with Obstructive Sleep Apnea	CI
05-15	Incannex Healthcare Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	CI

a137351b418b261fba56a6a8f78e.O06kJNQmWS1Zpd2p1PwzxdzWnE_VEYBhecihmJfMcro.dSTBSKdVFn0v0r7Ns59Sju24yT-fJ-ISH_jwyaWBGcxzGOAVjUFgQDSdtg~d26ff95cc0adccd99768517a096020eb